QIM
ENTA icon

Quantitative Investment Management’s Enanta Pharmaceuticals ENTA Stock Holding History

Quantitative Investment Management’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-22,300
Closed -$654K – 796
2016
Q1 		$654K Buy
+22,300
New +$621K 0.03% 493
2015
Q4 		– Sell
-7,800
Closed -$281K – 728
2015
Q3 		$281K Buy
+7,800
New +$335K 0.02% 553
2015
Q1 		– Sell
-5,200
Closed -$264K – 653
2014
Q4 		$264K Buy
+5,200
New +$233K 0.04% 372

Other funds holding ENTA

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return

Quantitative Investment Management's ENTA Position: Q2 2016 in Review

Quantitative Investment Management sold out of Enanta Pharmaceuticals (ENTA) in Q2 2016, closing a stake of 22,300 shares — an estimated $654K sold.

Quantitative Investment Management first reported a position in ENTA in Q4 2014 and held it in 3 quarters. The position peaked at $654K in Q1 2016. 129 funds tracked by Wall St. Rank hold ENTA as of Q2 2016.

  • Quantitative Investment Management reported no remaining Enanta Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
  • Quantitative Investment Management sold 22,300 Enanta Pharmaceuticals shares in Q2 2016, an estimated $654K.
  • Quantitative Investment Management first reported a position in Enanta Pharmaceuticals in Q4 2014 and held it in 3 quarters.
  • Quantitative Investment Management's Enanta Pharmaceuticals position peaked at $654K in Q1 2016.
  • 129 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q2 2016.

Based on Quantitative Investment Management's 13F filing for Q2 2016, filed 2 Aug 2016.